Why families had to protest and even litigate to get Skyclarys for Friedreich’s ataxia
But high-cost drugs can damage our health system by denying treatments to other patients
But high-cost drugs can damage our health system by denying treatments to other patients
Amid demand for best-in-class drugs, the State’s medicine bill is approaching €4bn annually
Patients and families are calling on the HSE to fund Skyclarys, a treatment they say could help slow progression of the rare disease
Meeting held with representatives from Biogen, which makes drug Skyclarys
Emily Felix (28) was 12 when she was diagnosed with Friedreich’s ataxia, a progressive neuromuscular disease
Pembro, made by pharma giant MSD, is hailed as a drug that saves and prolongs lives but it comes at an exorbitant cost
Review recommends HSE should highlight it does not support such pharmaceutical industry payments
Weight loss drug is not yet approved for reimbursement under Drug Payment Scheme or for medical card patients
Novo Nordisk’s Wegovy is about to enter the Irish market but people will have to pay for it from their own pocket - for now at least
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Pharma sector stakeholders still scoring points off each other despite new resources and talk of ‘shared purpose’
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices